Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso

Mol Genet Genomic Med. 2023 Apr;11(4):e2134. doi: 10.1002/mgg3.2134. Epub 2023 Jan 3.

Abstract

Background: Genetic alterations can result in DNA repair defects, increasing susceptibility to breast cancer. The aim of this study was to evaluate the involvement of two DNA repair genes, ERCC1 (rs3212986, GenBank NC_000073.9) and ERCC2 (rs1799793, rs13181, GenBank: NC_000019.10) in the occurrence of breast cancer in Burkina Faso.

Methods: This case-control study enrolled 128 participants including 64 patients and 64 healthy controls. Genotyping of polymorphisms were performed by real-time PCR and PCR-RFLP.

Results: The heterozygous AC genotype of the ERCC2rs13181 polymorphism was associated with the occurrence of breast cancer when the mutant allele is inherited under the dominant pattern (CC/AC vs AA; OR = 2.74, 95% IC (1.09-6.87); p = .028), but this association became insignificant after the Bonferroni correction (p = .156). No association was observed between ERCC1rs3212986 and ERCC2rs1799793 polymorphisms and breast cancer risk.

Conclusion: This study showed that the heterozygous genotype (CA) of the ERCC2rs13181 polymorphism may be associated with a risk of breast cancer.

Keywords: ERCC1; ERCC2; Burkina Faso; breast cancer; polymorphism.

MeSH terms

  • Breast Neoplasms* / genetics
  • Burkina Faso
  • Case-Control Studies
  • DNA Repair
  • DNA-Binding Proteins* / genetics
  • Endonucleases* / genetics
  • Female
  • Humans
  • Polymorphism, Single Nucleotide
  • Xeroderma Pigmentosum Group D Protein* / genetics

Substances

  • DNA-Binding Proteins
  • Endonucleases
  • ERCC1 protein, human
  • ERCC2 protein, human
  • Xeroderma Pigmentosum Group D Protein